Compare ACTG & USNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACTG | USNA |
|---|---|---|
| Founded | 1993 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Multi-Sector Companies | Medicinal Chemicals and Botanical Products |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 384.9M | 317.0M |
| IPO Year | 1995 | 1996 |
| Metric | ACTG | USNA |
|---|---|---|
| Price | $4.81 | $17.47 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 437.6K | 128.3K |
| Earning Date | 03-11-2026 | 04-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 161.11 | N/A |
| EPS | 0.22 | ★ 0.58 |
| Revenue | $12,004,000.00 | ★ $1,060,902,000.00 |
| Revenue This Year | N/A | $3.89 |
| Revenue Next Year | N/A | $6.22 |
| P/E Ratio | ★ $22.00 | $30.48 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.70 | $16.76 |
| 52 Week High | $5.21 | $38.32 |
| Indicator | ACTG | USNA |
|---|---|---|
| Relative Strength Index (RSI) | 58.84 | 43.14 |
| Support Level | $3.54 | $16.80 |
| Resistance Level | $5.21 | $18.11 |
| Average True Range (ATR) | 0.19 | 0.56 |
| MACD | -0.03 | 0.13 |
| Stochastic Oscillator | 29.52 | 59.63 |
Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, capital base, and deep industry relationships to drive value. The company has four reportable business segments: Intellectual Property Operations, Industrial Operations, Energy Operations and Manufacturing Operations. It derives revenue from Intellectual Property Operations segment. Geographically, it operates in Americas, Europe, Middle East and Africa, China, India, and Asia-Pacific, excluding China and India.
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.